Key result
A parallel second shock coil reduces S-ICD impedance by ~17 Ω versus conventional placement.
Why the study?
A subcutaneous implantable cardioverter-defibrillator system that defibrillates at lower energy could significantly reduce pulse generator size, but whether adding a second shock coil in parallel or transverse configurations acutely reduces defibrillation thresholds in humans required assessment.
Does adding a second shock coil reduce shock impedance and improve defibrillation success at lower energies in patients receiving a subcutaneous implantable cardioverter-defibrillator?
Does adding a second shock coil reduce shock impedance and improve defibrillation success at lower energies in patients receiving a subcutaneous implantable cardioverter-defibrillator?
Adding a second shock coil to an S-ICD system significantly lowers shock impedance and maintains high acute defibrillation success at ≤40 J, providing a pathway to develop smaller pulse generators.
Answers are grounded in this paper and cite their sources.
Supports lower-energy S-ICD generator development; extends acute parallel-coil efficacy data from this small RCT.
BackgroundThe subcutaneous implantable cardioverter-defibrillator (S-ICD) delivers 80 J shocks from an 8 cm left-parasternal coil to a 59 cm3 left lateral pulse generator (PG). A system that defibrillates with lower energy could significantly reduce PG size. Computer modeling and animal studies suggested that a second shock coil either parallel to the left-parasternal coil or transverse from the xiphoid to the PG pocket would significantly reduce the defibrillation threshold.ObjectiveThe purpose of this study was to acutely assess the defibrillation efficacy of parallel and transverse configurations in patients receiving an S-ICD.MethodsTesting was performed in patients receiving a conventional S-ICD system. Success at 65 J was required before investigational testing. A second electrode was temporarily inserted from the xiphoid incision connected to the PG with an investigational Y-adapter. Phase 1 (n = 11) tested the parallel configuration. Phase 2 (n = 21) tested both parallel and transverse configurations in random order.ResultsThis study enrolled 35 patients (28 males (80%); mean age 51 ± 17 years; left ventricular ejection fraction 40% ± 15%; body mass index 26 ± 4 kg/m2; prior myocardial infarction 46%; congestive heart failure 49%; cardiomyopathy 63%). Compared to the conventional S-ICD system, mean shock impedance decreased for both parallel (69 ± 15 Ω vs 86 ± 20 Ω; n = 33; P < .001) and transverse (56 ± 14 Ω vs 81 ± 21 Ω; n = 20; P < .001) configurations. Shock success rates at 20, 30, and 40 J were 55%, 79%, 97%, and 25%, 70%, 90% for parallel and transverse configurations, respectively. Defibrillation threshold testing was well tolerated with no serious adverse events.ConclusionAdding a second shock coil, particularly in the parallel configuration, significantly reduced the impedance and had a high likelihood of defibrillation success at energies ≤40 J. This may enable the development of a smaller S-ICD. The subcutaneous implantable cardioverter-defibrillator (S-ICD) delivers 80 J shocks from an 8 cm left-parasternal coil to a 59 cm3 left lateral pulse generator (PG). A system that defibrillates with lower energy could significantly reduce PG size. Computer modeling and animal studies suggested that a second shock coil either parallel to the left-parasternal coil or transverse from the xiphoid to the PG pocket would significantly reduce the defibrillation threshold. The purpose of this study was to acutely assess the defibrillation efficacy of parallel and transverse configurations in patients receiving an S-ICD. Testing was performed in patients receiving a conventional S-ICD system. Success at 65 J was required before investigational testing. A second electrode was temporarily inserted from the xiphoid incision connected to the PG with an investigational Y-adapter. Phase 1 (n = 11) tested the parallel configuration. Phase 2 (n = 21) tested both parallel and transverse configurations in random order. This study enrolled 35 patients (28 males (80%); mean age 51 ± 17 years; left ventricular ejection fraction 40% ± 15%; body mass index 26 ± 4 kg/m2; prior myocardial infarction 46%; congestive heart failure 49%; cardiomyopathy 63%). Compared to the conventional S-ICD system, mean shock impedance decreased for both parallel (69 ± 15 Ω vs 86 ± 20 Ω; n = 33; P < .001) and transverse (56 ± 14 Ω vs 81 ± 21 Ω; n = 20; P < .001) configurations. Shock success rates at 20, 30, and 40 J were 55%, 79%, 97%, and 25%, 70%, 90% for parallel and transverse configurations, respectively. Defibrillation threshold testing was well tolerated with no serious adverse events. Adding a second shock coil, particularly in the parallel configuration, significantly reduced the impedance and had a high likelihood of defibrillation success at energies ≤40 J. This may enable the development of a smaller S-ICD.
No takes yet. Share an insight, caveat, or question.
Yap et al. (2023) studied Patients scheduled to receive a conventional S-ICD system (n=35). Additional subcutaneous shock coil (parallel or transverse configuration) vs. Conventional S-ICD system (single left parasternal coil) was evaluated on Mean shock impedance (parallel configuration vs conventional) (p=<0.001). Adding a second shock coil in parallel reduced mean shock impedance compared to a conventional S-ICD system and achieved 97% defibrillation success at 40 J.
Synapse has enriched 10 related papers. Consider them for comparative context: